AUDA is primarily used in research settings to study its effects on inflammation and fibrosis. It acts as an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the metabolism of fatty acids. By inhibiting sEH, AUDA helps to increase the levels of epoxyeicosatrienoic acids (EETs), which are known to have anti-inflammatory and vasodilatory properties. This makes AUDA a valuable tool in investigating potential treatments for cardiovascular diseases, chronic pain, and kidney disorders. Additionally, its role in modulating lipid signaling pathways has sparked interest in its potential applications in metabolic and inflammatory diseases. Researchers also explore its utility in protecting against organ damage caused by ischemia-reperfusion injury.